Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,897.00    45.00 (1.58%)
Bid:
2,892.00
Ask:
2,894.00
Spread: 2.00 (0.069%)
Market Cap: £4.04b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Director/PDMR Shareholding

14 Jun 2010 16:35

RNS Number : 5915N
Croda International PLC
14 June 2010
 



Croda International Plc

 

14 June 2010

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

 

In accordance with Disclosure Rule 3.1.4R(1), I hereby inform you that Croda International Plc ("the Company") was notified on 14 June 2010, that the following transactions took place in relation to the Croda International Plc Share Incentive Plan ("SIP") on 10 June 2010. The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy ordinary shares in the Company of 10p each, using deductions from salary in each monthly pay period, and receive allocations of matching free ordinary shares ("matching shares").

 

1.

The SIP trustee (Capita IRG Trustees Limited) acquired 4,905 ordinary shares by purchase in the market on 10 June 2010 at a total cost of £50,803.03 and allocated them to employees participating in the SIP as partnership shares. 

 

2.

The SIP trustee (Capita IRG Trustees Limited) also acquired 4,905 ordinary shares by purchase in the market on 10 June 2010 at a total cost of £50,803.03 and allocated them to employees participating in the SIP as matching shares.

 

3.

The following directors and persons discharging managerial responsibilities purchased the number of ordinary shares of 10p set out against their names below, at a price of 1027p per ordinary share, and were allocated for no consideration the number of matching shares set out against their names below.

 

4..

In addition, some of the persons named in the table below opted to reinvest their dividend payment in the SIP. The SIP trustee (Capita IRG Trustees Limited) therefore also acquired 95 ordinary shares by purchase in the market at a price of 1027p per ordinary share on 10 June 2010 at a total cost of £983.95 on their behalf :

 

Name

Role

 

 

Number of ordinary

shares purchased

Number of matching

shares allocated

Number of ordinary shares purchased via dividend reinvestment

M Humphrey

Executive Director

12

12

N/A

M S Christie

Executive Director

12

12

N/A

D E Barraclough

PDMR

12

12

N/A

S E Foots

PDMR

12

12

N/A

K Layden

PDMR

12

12

N/A

G L Myers

PDMR

12

12

71

K M Nutbrown

PDMR

12

12

N/A

A L Scott

PDMR

12

12

24

 

This notification is made in order to satisfy both section 793 of the Companies Act 2006 and Disclosure and Transparency Rule 3.1.2.

 

 

 

 

Louise Scott

Company Secretary and Legal Counsel

Croda International Plc

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEZLFFBQFXBBZ
Date   Source Headline
19th Oct 202311:19 amRNSHolding(s) in Company
19th Oct 202310:34 amRNSDirector/PDMR Shareholding
12th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 20237:00 amRNSThird Quarter Trading Update
6th Oct 20234:12 pmRNSDirector/PDMR Shareholding
5th Oct 20238:53 amRNSHolding(s) in Company
3rd Oct 20234:03 pmRNSDirector/PDMR Shareholding
27th Sep 20235:17 pmRNSDirector/PDMR Shareholding
26th Sep 202311:38 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirectorate Change
15th Sep 202311:51 amRNSDirector/PDMR Shareholding
12th Sep 20234:01 pmRNSDirector/PDMR Shareholding
12th Sep 20238:56 amRNSDirector/PDMR Shareholding
11th Aug 20232:26 pmRNSDirector/PDMR Shareholding
1st Aug 20237:13 amRNSDirector Declaration
25th Jul 20237:00 amRNSResults for the six months ended 30 June 2023
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
4th Jul 20238:02 amRNSCroda completes acquisition of Solus Biotech
26th Jun 202310:46 amRNSHolding(s) in Company
13th Jun 20233:55 pmRNSDirector/PDMR Shareholding
12th Jun 20232:06 pmRNSDirector/PDMR Shareholding
9th Jun 20237:00 amRNSTrading update
31st May 20232:47 pmRNSDirector/PDMR Shareholding
26th May 20233:51 pmRNSDirector/PDMR Shareholding
11th May 20234:05 pmRNSDirector/PDMR Shareholding
3rd May 20233:08 pmRNSDirector/PDMR Shareholding
3rd May 20233:00 pmRNSDirector/PDMR Shareholding
2nd May 20232:30 pmRNSDirector/PDMR Shareholding
27th Apr 20239:18 amRNSResult of AGM
24th Apr 20234:49 pmRNSDirector/PDMR Shareholding
12th Apr 20232:00 pmRNSDirector/PDMR Shareholding
28th Mar 20233:51 pmRNSDirector/PDMR Shareholding
28th Mar 20233:50 pmRNSDirector/PDMR Shareholding
28th Mar 20233:47 pmRNSDirector/PDMR Shareholding
28th Mar 20233:46 pmRNSDirector/PDMR Shareholding
28th Mar 20233:44 pmRNSDirector/PDMR Shareholding
28th Mar 20233:42 pmRNSDirector/PDMR Shareholding
28th Mar 20233:41 pmRNSDirector/PDMR Shareholding
28th Mar 20233:41 pmRNSDirector/PDMR Shareholding
27th Mar 20233:52 pmRNSDirector/PDMR Shareholding
27th Mar 20233:48 pmRNSDirector/PDMR Shareholding
24th Mar 202310:57 amRNSDirector/PDMR Shareholding
24th Mar 202310:31 amRNSDirectorate Change
17th Mar 20235:12 pmRNSAnnual Financial Report
17th Mar 20232:30 pmRNSDirector/PDMR Shareholding
17th Mar 202310:53 amRNSDirector/PDMR Shareholding
13th Mar 20232:02 pmRNSDirector/PDMR Shareholding
3rd Mar 202311:57 amRNSDirector/PDMR Shareholding
28th Feb 20239:21 amRNSDirectorate Change
28th Feb 20237:00 amRNSResults for the year ended 31 December 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.